Guardant Health, Inc.

This study is testing whether a new blood test called GuardantLUNAR-2 can accurately detect lung cancer in people at high risk. It will enroll 12,000 current or former heavy smokers who are already scheduled for a standard CT scan. Researchers will compare the blood test results …